BRITTNEY PEMBER: Open Payments
NPI 1194277947 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 16 payments from 5 companies in 2025. Trend: 2023 $48 · 2024 $432 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $154 |
| Vanda Pharmaceuticals Inc. | 4 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, FANAPT, CAPLYTA, INGREZZA.
Industry payments across AR — which companies pay providers there.
